Garg Vipin K.'s Insider Trades & SAST Disclosures
Garg Vipin K.'s most recent trade in Altimmune Inc was a trade of 26,775 Restricted Stock Units done . Disclosure was reported to the exchange on Jan. 30, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Garg Vipin K..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 26,775 | 53,550 | - | - | Restricted Stock Units | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 26,775 | 342,696 (2%) | 0% | 0 | Common Stock, par value $0.0001 | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 18,950 | 18,950 | - | - | Restricted Stock Units | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 18,950 | 363,364 (2%) | 0% | 0 | Common Stock, par value $0.0001 | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 16,545 | 0 | - | - | Restricted Stock Units | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 16,545 | 351,645 (2%) | 0% | 0 | Common Stock, par value $0.0001 | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.00 per share. | 30 Jan 2025 | 11,701 | 330,995 (2%) | 0% | 7 | 81,907 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.64 per share. | 30 Jan 2025 | 8,282 | 355,082 (2%) | 0% | 6.6 | 54,992 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.64 per share. | 30 Jan 2025 | 7,231 | 344,414 (2%) | 0% | 6.6 | 48,014 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 5.18 per share. | 30 Jan 2025 | 4,105 | 335,100 (2%) | 0% | 5.2 | 21,264 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2025 | 477,500 | 477,500 | - | - | Stock Options (option to buy) | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2025 | 164,800 | 164,800 | - | - | Restricted Stock Units | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2025 | 42,050 | 334,078 (2%) | 0% | 0 | Common Stock, par value $0.0001 | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2025 | 42,050 | 126,150 | - | - | Restricted Stock Units | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.98 per share. | 25 Jan 2025 | 18,157 | 315,921 (2%) | 0% | 7.0 | 126,736 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
K. Vipin Garg | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 18,950 | 300,404 (1%) | 0% | 0 | Common Stock, par value $0.0001 | |
|
Altimmune Inc
|
K. Garg Vipin | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 18,950 | 37,900 | - | - | Restricted Stock Units | |
|
Altimmune Inc
|
Garg Vipin K. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 16,545 | 288,767 (1%) | 0% | 0 | Common Stock, par value $0.0001 | |
|
Altimmune Inc
|
Garg Vipin K. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 16,545 | 16,545 | - | - | Restricted Stock Units | |
|
Altimmune Inc
|
K. Garg Vipin | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.32 per share. | 01 Feb 2024 | 8,376 | 292,028 (1%) | 0% | 9.3 | 78,064 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
K. Garg Vipin | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.88 per share. | 01 Feb 2024 | 7,313 | 281,454 (1%) | 0% | 9.9 | 72,252 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Garg K. Vipin | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2024 | 26,775 | 80,325 | - | - | Restricted Stock Units | |
|
Altimmune Inc
|
K. Garg Vipin | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2024 | 26,775 | 276,030 (1%) | 0% | 0 | Common Stock, par value $0.0001 | |
|
Altimmune Inc
|
Vipin Garg K. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.80 per share. | 30 Jan 2024 | 11,697 | 264,333 (1%) | 0% | 9.8 | 114,631 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Garg Vipin K. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 2.69 per share. | 30 Jan 2024 | 7,889 | 272,222 (1%) | 0% | 2.7 | 21,221 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
K. Vipin Garg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 470,000 | 470,000 | - | - | Stock Options (option to buy) | |
|
Altimmune Inc
|
Garg K. Vipin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 168,200 | 168,200 | - | - | Restricted Stock Units | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 2.81 per share. | 31 Jul 2023 | 126 | 249,255 (1%) | 0% | 2.8 | 354 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 18,950 | 257,551 (1%) | 0% | 0 | Common Stock, par value $0.0001 | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 18,950 | 56,850 | - | - | Restricted Stock Units | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.04 per share. | 02 Feb 2023 | 8,422 | 249,129 (1%) | 0% | 15.0 | 126,667 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 16,546 | 33,090 | - | - | Restricted Stock Units | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 16,546 | 246,259 (1%) | 0% | 0 | Common Stock, par value $0.0001 | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.78 per share. | 31 Jan 2023 | 7,658 | 238,601 (1%) | 0% | 13.8 | 105,527 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 10.21 per share. | 31 Jan 2023 | 1,938 | 229,713 (1%) | 0% | 10.2 | 19,784 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 302,900 | 302,900 | - | - | Stock Options (option to buy) | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 107,100 | 107,100 | - | - | Restricted Stock Units | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.95 per share. | 30 Nov 2022 | 3,007 | 227,775 (1%) | 0% | 10.0 | 29,920 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.77 per share. | 30 Oct 2022 | 3,007 | 230,782 (1%) | 0% | 12.8 | 38,399 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.77 per share. | 30 Sep 2022 | 3,008 | 233,789 (1%) | 0% | 12.8 | 38,412 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.02 per share. | 30 Aug 2022 | 20,000 | 236,797 (1%) | 0% | 20.0 | 400,322 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.94 per share. | 30 Aug 2022 | 3,007 | 256,797 (1%) | 0% | 18.9 | 56,953 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.01 per share. | 30 Jul 2022 | 3,007 | 274,804 (1%) | 0% | 12.0 | 36,114 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.70 per share. | 30 Jun 2022 | 3,007 | 277,811 (1%) | 0% | 11.7 | 35,182 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.03 per share. | 30 May 2022 | 3,008 | 280,818 (1%) | 0% | 5.0 | 15,130 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.52 per share. | 30 Apr 2022 | 3,008 | 283,826 (1%) | 0% | 4.5 | 13,596 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.05 per share. | 30 Mar 2022 | 3,007 | 286,834 (1%) | 0% | 6.0 | 18,192 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.41 per share. | 28 Feb 2022 | 3,007 | 289,841 (1%) | 0% | 7.4 | 22,282 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 223,000 | 223,000 | - | - | Stock Options (option to buy) | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 75,800 | 75,800 | - | - | Restricted Stock Units | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 16,545 | 300,503 (1%) | 0% | 0 | Common Stock, par value $0.0001 | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 16,545 | 49,636 | - | - | Restricted Stock Units | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.98 per share. | 31 Jan 2022 | 7,655 | 292,848 (1%) | 0% | 8.0 | 61,087 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 6.86 per share. | 31 Jan 2022 | 2,757 | 283,958 (1%) | 0% | 6.9 | 18,913 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.20 per share. | 30 Jan 2022 | 2,355 | 281,201 (1%) | 0% | 7.2 | 16,956 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.49 per share. | 30 Nov 2021 | 3,007 | 286,563 (1%) | 0% | 10.5 | 31,543 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.80 per share. | 30 Oct 2021 | 3,007 | 289,570 (1%) | 0% | 10.8 | 32,476 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.31 per share. | 30 Sep 2021 | 3,007 | 292,577 (1%) | 0% | 11.3 | 34,009 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.09 per share. | 30 Aug 2021 | 3,008 | 295,584 (1%) | 0% | 14.1 | 42,383 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.07 per share. | 30 Jul 2021 | 3,007 | 298,592 (1%) | 0% | 9.1 | 27,273 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.85 per share. | 30 Jun 2021 | 3,007 | 301,599 (1%) | 0% | 9.9 | 29,619 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.65 per share. | 30 May 2021 | 2,577 | 304,606 (1%) | 0% | 12.6 | 32,599 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.47 per share. | 30 Apr 2021 | 1,999 | 307,183 (2%) | 0% | 14.5 | 28,926 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.55 per share. | 30 Mar 2021 | 1,998 | 309,182 (2%) | 0% | 13.6 | 27,073 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.94 per share. | 28 Feb 2021 | 1,998 | 311,180 (2%) | 0% | 15.9 | 31,848 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2021 | 241,500 | 241,500 | - | - | Stock Options (option to buy) | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2021 | 66,181 | 66,181 | - | - | Restricted Stock Units | |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 12.14 per share. | 31 Jan 2021 | 1,055 | 313,178 (2%) | 0% | 12.1 | 12,808 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.28 per share. | 30 Jan 2021 | 2,353 | 312,123 (2%) | 0% | 14.3 | 33,601 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.23 per share. | 30 Nov 2020 | 2,243 | 317,501 (2%) | 0% | 12.2 | 27,432 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.45 per share. | 30 Oct 2020 | 2,015 | 319,744 (2%) | 0% | 11.5 | 23,072 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.20 per share. | 30 Sep 2020 | 2,015 | 321,759 (2%) | 0% | 13.2 | 26,598 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.62 per share. | 30 Aug 2020 | 2,015 | 323,774 (2%) | 0% | 17.6 | 35,504 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.46 per share. | 31 Jul 2020 | 11,674 | 325,789 (2%) | 0% | 1.5 | 17,044 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.06 per share. | 30 Jul 2020 | 2,015 | 314,115 (2%) | 0% | 26.1 | 52,511 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.71 per share. | 30 Jun 2020 | 2,015 | 316,130 (2%) | 0% | 10.7 | 21,581 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.28 per share. | 30 May 2020 | 2,015 | 318,145 (2%) | 0% | 9.3 | 18,699 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.05 per share. | 30 Apr 2020 | 2,015 | 320,160 (2%) | 0% | 3.1 | 6,146 | Common Stock, par value $0.0001 |
|
Altimmune Inc
|
Vipin K. Garg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.02 per share. | 31 Mar 2020 | 2,016 | 322,175 (2%) | 0% | 3.0 | 6,088 | Common Stock, par value $0.0001 |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges